From this page You could reach all the figures at the Turkish Journal of Hematology archive.
You could save all the imges by the save as button and paste them to office documents.
Please use the articles details for reference.
You could see the abstracts of the images from the link above the image.
Search In Pictures
Search In Articles
All Types
Microscope display
FISH display
(MDCT),MRI,radiologic
Dermatologic
Other
55 records found...
The Prognostic Significance of the Serum p53 Protein Concentration in Chinese Patients with Non-Hodgkin Lymphoma
Figure 1: DLBCL karyotypes: 47; XY; del(1)(q41); l(2;18)(p13;q23); t(3;13)(q27;q14); +5[3]/46; XY[47].
The Prognostic Significance of the Serum p53 Protein Concentration in Chinese Patients with Non-Hodgkin Lymphoma
Figure 2: OS curve for bone marrow infiltration and noninfiltration.
The Prognostic Significance of the Serum p53 Protein Concentration in Chinese Patients with Non-Hodgkin Lymphoma
Figure 3: OS curve for low p53 protein level and high p53 Protein level
The Prognostic Significance of the Serum p53 Protein Concentration in Chinese Patients with Non-Hodgkin Lymphoma
Figure 4: OS curve for normal and abnormal karyotypes.
Hodgkin’s Lymphoma with Leptomeningeal Involvement
Figure 1: Bone lesions in lumbosacral vertebrae.
Hodgkin’s Lymphoma with Leptomeningeal Involvement
Figure 2: Leptomeningeal involvement (white arrow).
Primary Breast Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma Transformation to Diffuse Large B-cell Lymphoma: A Case Report
Figure 1: Small lymphoid cells infiltrating along the LCA and breast ducts, forming aggregates around the ducts (400x).
Primary Breast Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma Transformation to Diffuse Large B-cell Lymphoma: A Case Report
Figure 2: Diffuse infiltration pattern of the tumor removed from the breast tissue. Frequent mitosis and apoptosis can be seen inside the diffuse large B-cell lymphoma region, in which large centroblastic lymphoid cells are observed (HE, 400x).
Molecular Evaluation of t(14;18)(bcl-2/IgH) Translocation in Follicular Lymphoma at Diagnosis Using Paraffin-Embedded Tissue Sections
Figure 1: Representative gel photo of multiplex PCR results.Minor band shows PCR amplification products (120-200 bp). The band above shows the multiplex PCR strategy in which control primers were used to detect IgH/bcl-2 rearrangement. The first line represents the 50-bp DNA ladder [PUC 19 DNA/MspI (HpaII)]. Interpretation is as follows: Sample 1: MBR-negative case; samples 2 and 3: MBR-positive cases; sample 4: negative control.
Molecular Evaluation of t(14;18)(bcl-2/IgH) Translocation in Follicular Lymphoma at Diagnosis Using Paraffin-Embedded Tissue Sections
Figure 2: Representative gel photo of semi-nested PCR results. The first line on the left represents the 50-bp DNA ladder (Fermentas). Sample 1: MBR-positive control (Roche Diagnostic); samples 2-9: MBR-positive samples (each sample shows the PCR amplification products [50 bp] using primers specific to the bcl-2 MBR and JH consensus; sample 10: negative control.
1
2
3
4
5
6
Next Page >
Last Page >>
Sayfa 1 / 6 -- Toplam Kayıt 55 -- Listelenen kayıt sayısı 10
All Columns
Referance Numbers
Titles
Summeries
Keywords
0 records found...
1
Sayfa 1 / 1 -- Toplam Kayıt 0 -- Listelenen kayıt sayısı 0
AUTOIMMUNE DISORDERS (0 / 0)
Autoimmune Hemolytic Anemias (0 / 0)
Others (0 / 0)
CHEMOKINES (0 / 8)
Chemokines and cytokines (0 / 0)
Chemotactic Effects (0 / 2)
Other Effects (0 / 0)
Hematopoietic (0 / 0)
Angiogenic (0 / 0)
HIV Effects (0 / 6)
Regulation of Receptor Expression (0 / 0)
Signal Transduction (0 / 0)
CYTOGENETICS (0 / 2)
Gene Polymorphisms (0 / 2)
HEMOSTASIS (0 / 87)
Platelet and the vessel wall (0 / 13)
Blood coagulation (0 / 24)
Biology of hemostatic proteins (0 / 4)
Fibrinogen (0 / 0)
Vitamin K-dependent coagulation factors (0 / 0)
Coagulation factors (0 / 4)
Factor VIII-Factor IX-Factor XI (0 / 8)
Other coagulation factors (0 / 0)
Protein C anticoagulant pathway (0 / 0)
Other coagulation inhibitors (0 / 0)
Fibrinolytic enzymes and inhibitors (0 / 0)
Thrombotic Disorders (0 / 36)
Inherited coagulopathies (0 / 4)
Antithrombin deficiency (0 / 0)
Protein C deficiency (0 / 4)
Protein S deficiency (0 / 0)
Factor V Leiden mutation (0 / 0)
Prothrombin t20210A Mutation (0 / 0)
Acquired coagulation disorders (0 / 5)
Disseminated intravascular coagulation (0 / 5)
Liver Disease (0 / 0)
Vitamin K Deficiency (0 / 0)
Massive Transfusion Coagulapathies (0 / 0)
Acquired Inhibitors of coagulation proteins (0 / 0)
Replacement therapies (0 / 0)
Other therapies (0 / 0)
Cancer and thrombosis (0 / 3)
Antiphospholipid antibody syndrome (0 / 1)
Thrombotic thrombocytopenic purpura (0 / 1)
Heparin-induced thrombocytopenia (0 / 0)
Venous thromboembolism treatment (0 / 0)
Arterial thrombosis (0 / 13)
Antithrombotic therapy (0 / 6)
Heparin, low molecular weight heparin (0 / 3)
Direct thrombin inhibitors (0 / 0)
Oral anticoagulants (0 / 3)
Antifibrinolytic therapy (0 / 0)
Endothelium (0 / 1)
HEMATOLOGİC MANIFESTATİONS OF SYSTEMİC DISEASES (0 / 46)
GENE THERAPY (0 / 0)
HEMATOPOIESIS (0 / 8)
Stem and Primitive Progenitor Cells (0 / 0)
Red Blood Cells (0 / 0)
Granulocytes (0 / 1)
Lymphocytes (0 / 3)
Monocytes (0 / 0)
Eosinophilia (0 / 1)
Basophilia (0 / 0)
Megakaryocytes (0 / 3)
Mast Cells (0 / 0)
IRON (0 / 13)
Iron Deficiency (0 / 10)
Iron Overload (0 / 3)
IMMUNOLOGY (0 / 22)
Innate Immunity (0 / 0)
Immunoglobulins (0 / 16)
Antigen Recognition by T Lymphocytes (0 / 0)
The Development of B Lymphocytes (0 / 0)
T-Cell Mediated Immunity (0 / 0)
The Humoral Immune Response (0 / 0)
Immundeficiency dieases (0 / 0)
Allergy and Hypersensitivity (0 / 3)
Immune Response Disorder (0 / 3)
Autoimmunity: responses to self antigens (0 / 2)
Transplant rejection: responses to alloantigens (0 / 0)
Tumor immunology (0 / 0)
Lymphoid Cells Neoplasms (0 / 0)
B-cell neoplasms (0 / 0)
T-cell neoplasms (0 / 0)
NK cell neoplasms (0 / 0)
Others (0 / 0)
INFECTION (0 / 16)
Febril Neutropenia (0 / 6)
Viral Infections (0 / 1)
Fungan Infections (0 / 1)
Bacterial Infections (0 / 2)
Parasitic Infections (0 / 2)
MARROW (0 / 9)
Physiology of Hematopoiesis (0 / 5)
Bone Marrow Failure (0 / 1)
Acquired Aplastic Anemia (0 / 3)
Fanconi Anemia (0 / 0)
Inherited Pure Red Cell Anemia (0 / 0)
Acquired Pure Red Cell Anemia (0 / 0)
STEM CELL TRANSPLANTATION (0 / 54)
Stem cell physiology (0 / 9)
Stem cell mobilization (0 / 0)
Immunologic tolerance (0 / 0)
Graft rejection (0 / 0)
Conditioning regimen (0 / 0)
Allo transplantation (0 / 18)
Auto transplantation (0 / 2)
Non myeloablative (0 / 0)
Organ Specific Toxicity (0 / 3)
Clinical Care of Graft-Versus-Host Disease (0 / 10)
Acute GVHD (0 / 0)
Chronic GVHD (0 / 10)
NEOPLASIA (0 / 354)
Pediatric hematologic Malignancies (0 / 3)
Pediatric Leukemia (0 / 8)
Pediatric Lymphomas (0 / 2)
Acute Leukemia (0 / 12)
Acute Lymphoblastic Leukemia (0 / 36)
Acute Myeloblastic Leukemia (0 / 66)
Myelodysplastic Syndromes (0 / 3)
Chronic Leukemia (0 / 0)
Chronic Lymphocytic Leukemia (0 / 7)
Chronic Myeloid Leukemia (0 / 18)
Other Lymphoproliferative Disorders (0 / 2)
Other Leukemias (0 / 12)
Lymphomas (0 / 37)
Hodgkin Lymphoma (0 / 10)
Non Hodgkin Lymphoma (0 / 45)
Chronic Myeloproliferative Neoplasms (0 / 32)
Pharmacotherapeutics (0 / 3)
Oncogenes (0 / 0)
Multipl myeloma (0 / 45)
Plasmacytoma (0 / 2)
Cryoglobulinemia (0 / 2)
Plasma Cell Disorders (0 / 7)
PHAGOCYTES (0 / 16)
Neutrophils (0 / 4)
Monocytes and Macrophages (0 / 3)
Eosinophils (0 / 3)
Basophils (0 / 0)
Mast cells (0 / 0)
Dendritic cells (0 / 6)
Chemotaxis (0 / 0)
Antigen presentation (0 / 0)
Phagocytosis, cytotoxicity (0 / 2)
PLATELETS (0 / 34)
Physiology of Normal Platelets (0 / 10)
Signal Transduction (0 / 0)
Disorders of Platelets (0 / 12)
von Willebrand Disease (0 / 7)
Acquired Platelet Disorders (0 / 0)
Autoimmune and Alloimmune platelet disorders (0 / 2)
RED CELLS (2 / 92)
Hemoglobin disorders (0 / 6)
Anemia (2 / 40)
Nutritional anemia (0 / 9)
iron, cobalamin, folate deficiency (0 / 7)
Fanconi Anemia (0 / 1)
Aplastic Anemia (0 / 6)
Myeloproliferative and myelodysplasia (0 / 0)
Immune Hemolytic anemias (2 / 12)
Red cell membrane disorders (0 / 7)
Paroxymal Nocturnal hemoglobin (PNH) (0 / 0)
Enzyme disorders (0 / 0)
Sickle cell anemia (0 / 4)
Thalassemia (0 / 19)
Other hemoglobinopathies (0 / 11)
Polycythemia (0 / 4)
Polycythemia Vera (0 / 3)
Secondary Polycythemia (0 / 0)
WHITE CELLS (0 / 4)
Congenital Neutropenia (0 / 3)
Acquired Neutropenia (0 / 0)
Leucocyte Function Disorders (0 / 0)
Lymphocytes (0 / 0)
SUPPORTIVE CARE (0 / 0)
MOLECULAR HEMATOLOGY (0 / 6)
TRANSFUSION MEDICINE (0 / 10)
Apheresis (0 / 4)
Red Blood Cells (0 / 3)
White cell transfusions (0 / 1)
Platelet transfusions (0 / 0)
VASCULAR BIOLOGY (0 / 0)
OTHER (325 / 85)
FLOW CYTOMETRY (0 / 2)
STORAGE DISORDERS (0 / 14)
Spleen (0 / 1)
Experimental Hematology (0 / 3)
IRRADIATION (0 / 3)
Copyright © 2023 Atlas of Hematology. All rights reserved.
LookUs
&
OnlineMakale